Dr. Kuno: Preclinical Studies Show Ivermectin Triggers Cancer Cell Apoptosis
Dr. Jonas Kuno · Chasing Wealth, Neglecting Health — The Real Consequences. · Feb 16, 2026 · at 13:07
Regenerative medicine physician Dr. Jonas Kuno discusses the preclinical research surrounding repurposed off-patent drugs like ivermectin and mebendazole in oncology.
0:00 / 0:21exact quote · 21.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“There's a combination of what is it? Mabendazole and ivermectin, for example. Couldn't say that word like three years ago, you know, but again, this was something that predates COVID. It's been studied to treat cancer. Has some good mechanism where triggers apoptosis of cancer cells. This is the ivermectin part. And even I believe cancer stem cells, and this is all preclinical. These are not clinical trials.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Dr. Jonas Kuno
Kuno: Cryotherapy enables rheumatoid arthritis patients to stop immunosuppressive drugs
“So we have people as an example with rheumatoid arthritis, and many of them were on immunosuppressive agents. You've heard about Humira and all these advertised, right? They bring your immune system down to manage the overreaction that causes this joint proble…”
Kuno: Umbilical cord stem cells recognize cancer cells and trigger apoptosis
“Umbilical cord stem cells are from newborns, from healthy c-section births. It's the birth tissue that usually gets discarded. Now, these cells don't have a fingerprint. They become your own cells to some extent, but they also recognize cancer cells, and they …”
Dr. Jonas Kuno: Low-dose naltrexone improves cancer outcomes by reducing inflammation
“One of the latest things in cancer research, which was interesting, there is a Microinflammatory environment that cancer cells need to thrive. They don't need oxygen. They like a low oxygen environment and they like an inflammatory environment. And so they're …”
Kuno Refuses to Prescribe GLP-1 Drugs Citing Long-Term Unknowns
“So we do use medications. I don't use GLP-I's. I mean, I'm a bit again, there's still some unknowns and long-term issues that I have with them, but we use traditional weight loss medications.”
Dr. Kuno: Cancer Cells Rely on Fermentation Due to Mitochondrial Dysfunction
“And when you look at cancer cells, they have malfunctioning mitochondria. The mitochondria can't do this elaborate Citric acid cycle where they take sugar and makes 36 ATP per molecule. They can only ferment. It's a very primitive way of energy production, two…”